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A straightforward estimation of cardiac substructure 
exposure for clinical practice: example of breast rotational 
intensity modulated radiation therapy
Pierre Loap, Youlia Kirova
Institut Curie, Paris, France
Introduction. Mean heart dose (MHD) is the most widely used dosimetric parameter for cardiac sparing during treatment 
planning. Specific cardiac substructure exposure could be more clinically important, but MHD cannot provide the radiation 
oncologist with precise insight at the substructural level.
Materials. We propose a straightforward method for estimating cardiac substructure exposure based on linear regressions 
between mean dose delivered to cardiac substructures and MHD. We focused on breast irradiation with intensity modulated 
radiation therapy as an application example. Correlations between mean dose to cardiac substructures and MHD were 
statistically significant and usually moderate (r > 0.5) or strong (r > 0.7), allowing the use of such linear regression models 
to estimate cardiac substructure exposure from MHD for clinical practice.
Conclusion. This method can be extrapolated to other clinical situations for daily practice, albeit with some restrictions.
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Introduction 
Adjuvant radiation therapy decreases breast cancer mor-
tality but poses cardiotoxicity risks [1]. Fortunately, recent 
techniques efficiently spare the heart [2], such as rotatio-
nal intensity modulated radiation therapy (IMRT) or proton 
radiation therapy. However, the heart is a complex organ 
made of multiple histologically-diverse substructures and 
the widely used mean heart dose (MHD) cannot provide 
a precise insight at the substructural level. In this perspec-
tive, we propose a straightforward method for estimating 
mean doses to cardiac substructures when only MHD is 
known (which is the case for clinical practice), focusing on 
locoregional breast cancer irradiation using rotational IMRT 
as an application example.
Materials
Thirty breast cancer patients having undergone breast con-
servation surgery and subsequently irradiated with rotational 
IMRT (volumetric modulated arc therapy or helical tomothera-
py) were selected by random sampling from our institutional 
database. Sixteen patients were treated for left-sided breast 
cancers and 14 for right-sided breast cancers. Target volumes 
included the whole breast with a boost, homolateral axillary 
lymph nodes and internal mammary chain. Half of the radiation 
schedules were hypofractionated: hypofractionated regimens 
delivered 52.2 to 56 Gy to the tumour bed (in 18 to 23 fractions) 
while normofractionated regimens delivered 63 to 66 Gy. 
Cardiac substructures were delineated according to published 
international guidelines [3]. Mean doses to the heart (MHD), 
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left-sided irradiations and the proximal segment of the right 
coronary artery (β = 1.6, p < 0.001) for right-sided irradiations. 
For right-sided irradiations, the correlations were usually 
strong (r > 0.7). Correlations were somewhat weaker for left-si-
ded irradiations, but the correlation coefficient was still usually 
greater than 0.5. The greatest correlation with the MHD was 
found for the distal circumflex artery segment for left-sided 
irradiations (r = 0.88, p < 0.001) and for the left ventricle septal 
wall (r = 0.95, p < 0.001) for right-sided irradiations. 
Discussion
Based on simple linear regressions, this method for estimating 
cardiac substructure exposure is straightforward and conve-
nient when only MHD is available, which is often the case 
in daily practice since cardiac substructures are usually not 
cardiac cavities, left ventricular walls and coronary arteries were 
retrieved. For each substructure, a simple linear regression was 
performed between the mean dose to the considered cardiac 
substructure and the MHD.
Results
For all substructures, MHD was a significant explanatory vari-
able (with the exception of the first two right coronary artery 
segments for left-sided irradiation). The cardiac substructures 
which were the most sensitive to MHD variation were the left 
ventricle anterior wall (β = 1.8, p < 0.001) for left-sided irradi-
ations and the right auricle (β = 1.3, p < 0.001) for right-sided 
irradiations. The coronary artery segments which were the 
most sensitive to MHD variation were the mid segment of the 
left anterior descending coronary artery (β = 2.9, p < 0.001) for 
b. Linear models for coronary artery segmentation
Coronary artery segmentation
Left-sided breast irradiation Right-sided breast irradiation
Mean dose r p value Mean dose r p value
Left main coronary artery = 0.8 x MHD + 1.0 0.59 0.001 = 1.0 x MHD + 0.3 0.77 <0.001
Left anterior descending artery (LADCA) = 2.6 x MHD – 1.2 0.64 <0.001 = 0.8 x MHD + 0.3 0.73 0.001
LADCA proximal segment = 2.4 x MHD – 5.3 0.70 <0.001 = 0.7 x MHD + 1.3 0.70 0.001
LADCA mid segment = 2.9 x MHD – 1.3 0.53 0.004 = 0.9 x MHD + 0.7 0.55 0.007
LADCA distal segment = 2.0 x MHD + 5.5 0.27 0.069 = 0.8 x MHD – 0.6 0.68 0.001
Circumflex artery (CxA) = 0.8 x MHD – 0.7 0.86 <0.001 = 0.7 x MHD – 0.5 0.86 <0.001
CxA proximal segment = 1.0 x MHD – 0.5 0.65 <0.001 = 0.8 x MHD – 0.2 0.76 <0.001
CxA distal segment = 0.7 x MHD – 1.0 0.88 <0.001 = 0.6 x MHD – 0.5 0.83 <0.001
Right coronary artery (RCA) = 0.7 x MHD + 0.9 0.52 0.004 = 1.2 x MHD – 0.2 0.86 <0.001
RCA proximal segment = 0.6 x MHD + 3.3 0.24 0.070 = 1.6 x MHD + 1.3 0.76 <0.001
RCA mid segment = 0.5 x MHD + 2.8 0.09 0.215 = 1.5 x MHD – 1.5 0.81 <0.001
RCA distal segment = 0.5 x MHD + 0.2 0.50 0.004 = 0.9 x MHD – 1.0 0.72 0.001
RCA posterior descending segment = 1.1 x MHD – 1.9 0.67 <0.001 = 0.6 x MHD – 0.6 0.78 <0.001
r is the correlation coefficient, p values are adjusted for multiple testing with Holm-Bonferroni method. 
Table I. Provides the equations estimating the mean dose delivered to each substructure from MHD 
a. Linear models for cardiac substructure
Cardiac substructure
Left-sided breast irradiation Right-sided breast irradiation
Mean dose r p value Mean dose r p value
Left ventricle (LV) = 1.0 x MHD – 0.4 0.84 <0.001 = 0.7 x MHD – 0.7 0.95 <0.001
LV anterior wall = 1.8 x MHD – 2.1 0.73 <0.001 = 0.7 x MHD + 0.1 0.81 <0.001
LV apical wall = 1.4 x MHD + 0.7 0.35 0.031 = 0.6 x MHD – 0.5 0.76 <0.001
LV lateral wall = 1.0 x MHD – 0.9 0.81 <0.001 = 0.6 x MHD – 0.7 0.94 <0.001
LV inferior wall = 0.6 x MHD – 0.3 0.76 <0.001 = 0.6 x MHD – 0.7 0.87 <0.001
LV septal wall = 0.9 x MHD – 0.1 0.85 <0.001 = 0.9 x MHD – 0.9 0.95 <0.001
Right ventricle = 1.0 x MHD + 0.2 0.80 <0.001 = 1.0 x MHD – 0.6 0.92 <0.001
Left auricle = 0.6 x MHD + 0.3 0.70 <0.001 = 1.0 x MHD – 0.7 0.91 <0.001
Right auricle = 0.5 x MHD + 0.8 0.77 <0.001 = 1.3 x MHD – 0.3 0.80 <0.001
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routinely delineated. This approach, illustrated herein for breast 
rotational IMRT, can be extrapolated to other clinical situations 
where cardiac radiation exposure is concerned.
And yet, these linear models based on MHD must be used 
with some caution.  While correlations between MHD and 
mean dose to cardiac substructures were strong for right-sided 
irradiations, they were more moderate for left-sided irradia-
tions: in this case, a part of the substructure exposure cannot 
be explained by MHD variation, generating an uncertainty in 
its estimation. In addition, MHD provides no information on 
high doses to cardiac substructures. The histological diversity 
of the cardiac substructure (muscle, nerves, epithelial tissues, 
and lymphatic and blood tissue) explains the broad range of 
described radiation-induced adverse cardiac events [4]: spe-
cific cardiac substructure doses may thus be more important 
than MHD. For instance, atrial dose correlates with specific 
cardiotoxicity for lung cancer patients [5–6]. Even though 
substructure dose constraints are not precisely known yet, 
toxicity studies taking into account cardiac segmentation may 
help clarifying them.  
Conclusions
Clinical practice and cardiotoxicity trials would gain by con-
sidering cardiac substructure exposure; relying solely on the 
MHD for cardiac sparing may be simplistic, but linear regression 
models can help in estimating cardiac substructure exposure 
when only MHD is available. 
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